#IMPower150
Preparing to give my first lecture to heme/onc fellows as a faculty. Will be talking about driver negative metastatic NSCLC.

Planning to talk about KN001, KN024, KN189, KN407, CM227, CM9LA, IMPower150. What else should I cover? #MedSky #LCSM
November 24, 2024 at 8:22 PM
🌍 Regional Context
❌ Unlike global #IMPower150 (which showed significant PFS/OS benefits), #IMPower151 highlights differences in Asian vs. Western populations: 53% had #EGFR mutations (vs. 14% in IMP150) and 97% used pemetrexed (vs. paclitaxel in IMP150).

#Onco404 #Cancer #Kanser #MedSky #OncSky
May 20, 2025 at 3:34 PM
FLAURA2 regimen now reimbursed. I have some questions. Who needs chemo? Everyone? Selected pts? Access to other therapies - assume Impower150 not available to patient who have had Chemo-Osi?
Is chemo-Osi likely better than sequencing Osi-IMPOWER 150?

Lung cancer keeps getting more complex!
April 10, 2025 at 10:26 AM